Yantai Zhenghai Biotechnology Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Kan Song

Amministratore delegato

CN¥1.1m

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	1.9yrs
Proprietà del CEO	n/a
Durata media del management	4.6yrs
Durata media del Consiglio di amministrazione	5.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Kan Song (41 yo)

1.9yrs

Mandato

CN¥1,116,100

Compensazione

Mr. Kan Song is Chairman since April 12, 2023 & General Manager and Director of Yantai Zhenghai Biotechnology Co., Ltd. from January 06, 2023. He is Secretary of Yantai Zhenghai Biotechnology Co., Ltd sinc...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Kan Song	GM, Secretary & Chairman	1.9yrs	CN¥1.12m	Nessun dato
Li Zhao	Deputy GM	no data	CN¥904.90k	Nessun dato
Xing Yang	Deputy General Manager	4.6yrs	CN¥1.52m	Nessun dato
Donggang Zhang	Deputy General Manager	7.3yrs	CN¥907.90k	Nessun dato

4.6yrs

Durata media

46.5yo

Età media

Gestione esperta: Il team dirigenziale di 300653 è considerato esperto (durata media dell'incarico 4.6 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Kan Song	GM, Secretary & Chairman	1.8yrs	CN¥1.12m	Nessun dato
Li Zhao	Deputy GM	4.5yrs	CN¥904.90k	Nessun dato
Dong Qun	Vice Chairman	9.4yrs	Nessun dato	Nessun dato
Chao Zhang	Non-Independent Director	6.6yrs	Nessun dato	Nessun dato
Weiguo Jiang	Non-Independent Director	5.2yrs	Nessun dato	Nessun dato
Hui Xu	Independent Director	3.6yrs	CN¥60.00k	Nessun dato
Xiliang Song	Independent Director	3.6yrs	CN¥60.00k	Nessun dato
Landing Zhang	Independent Director	3.6yrs	CN¥60.00k	Nessun dato
Yueli Xu	Chairman of the Supervisory Board	9.4yrs	Nessun dato	Nessun dato
Lishan Pan	Non-Employee Supervisor	5.2yrs	Nessun dato	Nessun dato
Lei Zhao	Employee Supervisor	9.4yrs	Nessun dato	Nessun dato

5.2yrs

Durata media

49yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 300653 sono considerati esperti (durata media dell'incarico 5.2 anni).

Yantai Zhenghai Biotechnology Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.21 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

New major risk - Share price stability

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 16%

Now 22% overvalued

Now 20% overvalued

Investor sentiment deteriorates as stock falls 17%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.31 in 2Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2024 Results on Aug 06, 2024

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.30 in 1Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥1.06 (vs CN¥1.28 in FY 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 15%

Yantai Zhenghai Biotechnology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.28 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.31 (vs CN¥0.27 in 2Q 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2023 Results on Aug 01, 2023

Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023

Now 29% undervalued after recent price drop

Full year 2022 earnings released: EPS: CN¥1.28 (vs CN¥0.93 in FY 2021)

Full year 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.93 in FY 2021)

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

Now 26% undervalued after recent price drop

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.21 in 2Q 2021)

Investor sentiment improved over the past week

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.37 in 1Q 2021)

Yantai Zhenghai Biotechnology Co., Ltd. Proposes Distribution for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.34 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.30 in 2Q 2020)

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 20, 2021

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.16 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.99 (vs CN¥0.89 in FY 2019)

New 90-day low: CN¥45.02

New 90-day low: CN¥49.35

New 90-day low: CN¥52.20

New 90-day low: CN¥57.91

New 90-day low: CN¥61.00

Third quarter earnings released

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media